# Frank Fangliang Zhang

> Frank Fangliang Zhang is the chairman of Legend Biotech and a co-founder and executive director of GenScript Biotech. A Duke-trained biochemist, he worked at Schering-Plough before co-founding GenScript in 2002, founded Legend as a subsidiary in 2015, briefly served as Legend CEO in 2020, and returned to its chairmanship in 2022.

- **Role:** Chairman of the Board at Legend Biotech
- **Organizations:** Legend Biotech, GenScript Biotech, Schering-Plough, Huazhong University of Science and Technology
- **Nationality:** Chinese
- **Education:** Bachelor of Engineering, Chengdu College of Geology (now Chengdu University of Technology), Master of Science, Nanjing University, PhD in biochemistry, Duke University
- **Known for:** Co-founded GenScript and founded Legend Biotech as a subsidiary., Received Schering-Plough’s Presidential Award in 2001., Legend’s August 2022 biography credited him with more than 20 peer-reviewed articles and nine scientific patents.

## Career timeline

- **1995-2002** — Scientific research roles at Schering-Plough; received its Presidential Award in 2001.
- **2002** — Co-founded GenScript in New Jersey.
- **2004** — GenScript began operating in Nanjing, approximately two years after founding.
- **2009** — GenScript announced $15 million in venture financing.
- **2015** — GenScript listed in Hong Kong; Zhang founded Legend as a subsidiary and became its chairman.
- **2020-06** — Legend began Nasdaq trading under LEGN on June 5.
- **2020-08 to 2020-09** — Served as Legend CEO after stepping down as GenScript CEO.
- **2020-11** — Resigned from Legend and GenScript boards during a Chinese customs investigation.
- **2022-05** — GenScript reported that the procuratorate decided not to bring any charges against any entity or individual; Zhang rejoined its board.
- **2022-08** — Elected chairman of Legend Biotech.
- **2022-12** — Redesignated as GenScript executive director.

## Achievements

- Co-founded GenScript and founded Legend Biotech as a subsidiary.
- Received Schering-Plough’s Presidential Award in 2001.
- Legend’s August 2022 biography credited him with more than 20 peer-reviewed articles and nine scientific patents.
- Named with Sherry Shao as an EY Entrepreneur Of The Year 2026 New Jersey finalist.

## Latest updates

- **2026-09** — As Legend chairman, commented on Ingrid Zhang’s September 15 appointment as CEO after a board-led search.
- **2026-05** — Published public commentary on globally dependable execution and delivery.
- **2026-04** — EY named Zhang and Sherry Shao as New Jersey Entrepreneur Of The Year finalists.

## Links

- LinkedIn: https://www.linkedin.com/in/frank-zhang-b4907611

---

Profile page: https://yespress.io/frank-fangliang-zhang
Published by YesPress — https://yespress.io
Last updated: 2026-10-13